Literature DB >> 8308112

Evaluation of Clearview and Magic Lite tests, polymerase chain reaction, and cell culture for detection of Chlamydia trachomatis in urogenital specimens.

J A Kluytmans1, W H Goessens, J W Mouton, J H van Rijsoort-Vos, H G Niesters, W G Quint, L Habbema, E Stolz, J H Wagenvoort.   

Abstract

The Clearview Chlamydia test (CV; Unipath Ltd., Bedford, United Kingdom), the Magic Lite Chlamydia test (ML; CIBA Corning, Medfield, Mass.), a polymerase chain reaction (PCR), and cell culture (CC) were evaluated for detection of Chlamydia trachomatis in urogenital specimens. Specimens were collected from 283 men and 724 women visiting the outpatient clinic for Sexually Transmitted Diseases at the University Hospital Rotterdam, Rotterdam, The Netherlands. ML, PCR, and CC were all performed on the same sample to prevent swab-to-swab variability. CV was performed on a separate sample. Analysis of discordant results was performed by application of the following confirmatory assays: first, PCR on the CC, second, ML was repeated, and third, PCR was repeated by using a different DNA extraction protocol. If more than one test was positive, the sample was considered true positive. If only one test was positive, which was confirmed by the confirmatory assay, the sample was also considered true positive. By using these interpretations, the following results were obtained. The sensitivity and specificity of CV for samples from men were 60.4 and 86.3%, respectively. For samples from women, these values were 62.3 and 99.7%, respectively. The low specificity for samples from men was caused by unidentified substances in the swab that was used. The use of CV on samples from men is not recommended by the manufacturer. For samples from women, the specificity of CV was high, but the low sensitivity of CV limits its use for diagnostic purposes. The sensitivities of ML were low for samples from both men and women (68.8% and 50.9% respectively), while specificities were excellent for samples from both groups (100 and 99.9%, respectively). The low sensitivity of ML limits its diagnostic value. The PCR technique was highly specific for samples from both men (99.6%) and women (99.9%). The sensitivity of PCR, however, was unexpectedly low for samples from both groups (men, 87.5%; women, 79.2%), most likely because of the sample treatment method used. The sensitivity and specificity values of CC for samples from men were 95.8 and 100%, respectively. For samples from women, these values were 100 and 99.9%, respectively. In the present study, CC was the most reliable technique for the detection of C. trachomatis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8308112      PMCID: PMC266376          DOI: 10.1128/jcm.31.12.3204-3210.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

Review 1.  Genital Chlamydia infections.

Authors:  J M Ehret; F N Judson
Journal:  Clin Lab Med       Date:  1989-09       Impact factor: 1.935

2.  Comparison of HeLa 229 and McCoy cell cultures for detection of Chlamydia trachomatis in clinical specimens.

Authors:  E A Thewessen; I Freundt; J H van Rijsoort-Vos; E Stolz; M F Michel; J H Wagenvoort
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

3.  Serovar distribution of urogenital Chlamydia trachomatis strains in The Netherlands.

Authors:  J H Wagenvoort; R J Suchland; W E Stamm
Journal:  Genitourin Med       Date:  1988-06

4.  Effect of swab type and storage temperature on the isolation of Chlamydia trachomatis from clinical specimens.

Authors:  J B Mahony; M A Chernesky
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

5.  Enhancement of yield of Chlamydia trachomatis Hela 229 cell culture.

Authors:  J T Wagenvoort; T van Rijsoort-Vos; A Overkleeft-van de Ree; E Stolz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

6.  Survival of Chlamydia trachomatis in different transport media and at different temperatures: diagnostic implications.

Authors:  K H Tjiam; B Y van Heijst; J C de Roo; A de Beer; T van Joost; M F Michel; E Stolz
Journal:  Br J Vener Dis       Date:  1984-04

7.  Evaluation of a new chemiluminometric immunoassay, Magic Lite Chlamydia, for detecting Chlamydia trachomatis antigen from urogenital specimens.

Authors:  C Scieux; A Bianchi; I Vassias; R Meouchy; A Felten; P Morel; Y Perol
Journal:  Sex Transm Dis       Date:  1992 May-Jun       Impact factor: 2.830

Review 8.  Diagnosis of Chlamydia trachomatis genitourinary infections.

Authors:  W E Stamm
Journal:  Ann Intern Med       Date:  1988-05       Impact factor: 25.391

9.  Characterization and sequence of a plasmid from the trachoma biovar of Chlamydia trachomatis.

Authors:  K S Sriprakash; E S Macavoy
Journal:  Plasmid       Date:  1987-11       Impact factor: 3.466

Review 10.  Laboratory diagnosis of human chlamydial infections.

Authors:  R C Barnes
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

View more
  19 in total

1.  Development of a new serum-free cell culture system, McCoy-Plovdiv.

Authors:  M Draganov; M Murdjeva; E Kamberov
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-05       Impact factor: 2.416

2.  Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine.

Authors:  W H Goessens; J W Mouton; W I van der Meijden; S Deelen; T H van Rijsoort-Vos; N Lemmens-den Toom; H A Verbrugh; R P Verkooyen
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

3.  Guidelines for cultivation and preservation of the serum-free cell line McCoy-Plovdiv.

Authors:  Marian M Draganov; Marianna A Murdjeva; Victoria S Sarafian
Journal:  Cytotechnology       Date:  2003-09       Impact factor: 2.058

4.  Evaluation of Clearview Chlamydia.

Authors:  I Davidson; L Roberts
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

5.  Comparison of the PACE 2 assay, two amplification assays, and Clearview EIA for detection of Chlamydia trachomatis in female endocervical and urine specimens.

Authors:  T L Lauderdale; L Landers; I Thorneycroft; K Chapin
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

6.  Impact of reference standard sensitivity on accuracy of rapid antigen detection assays and a leukocyte esterase dipstick for diagnosis of Chlamydia trachomatis infection in first-void urine specimens from men.

Authors:  M Chernesky; D Jang; J Krepel; J Sellors; J Mahony
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

7.  Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.

Authors:  H D Davies; E E Wang
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

8.  The laboratory diagnosis of Chlamydia trachomatis infections.

Authors:  Max A Chernesky
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-01       Impact factor: 2.471

9.  Influence of volume of sample processed on detection of Chlamydia trachomatis in urogenital samples by PCR.

Authors:  W H Goessens; J A Kluytmans; N den Toom; T H van Rijsoort-Vos; B G Niesters; E Stolz; H A Verbrugh; W G Quint
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

10.  Solid-phase C1q-directed bacterial capture followed by PCR for detection of Chlamydia trachomatis in clinical specimens.

Authors:  P Herbrink; H A van den Munckhof; H G Niesters; W H Goessens; E Stolz; W G Quint
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.